The development of dual GIPRGLP1R coagonists that bind to either one or the other receptor (sequence-mixed dual agonists) has emerged as an innovative therapeutic strategy for obesity and type 2 diabetes
Assefa, Biruhalem, et al
This article explains exactly why GLP-1 medications can trigger hair loss, who is most at risk, what the current medical literature says, and, most importantly, the full spectrum of treatment options available today, from topical and oral medications to PRP, Exosome Hair Therapy, and FUE Hair Transplant
Clinical studies indicate that women using certain GLP-1 treatments can achieve significant weight loss, often exceeding 15% of their total weight, with some reporting reductions of 20-25% within a year
KEY OBSERVATIONS IVY RXs website claims medications are compounded in pharmacies compliant with 503B/USP standards. The pharmacy that shipped my order is 503A